BIOHAVEN LTD
BHVNNYSE🏆 #1833 by market capEarnings Nov 9US Equity
$14.39▼ $0.10 (−0.69%)
🌙 After hours$14.15▼ 1.67%Regular close · extended-hours price shown1h—
24h▼ 0.7%
7d▼ 0.3%
14d▲ 4.0%
30d▼ 3.6%
1y▲ 0.1%
🏦Market Cap
$2.17B
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
41
Weak
📊
Analyst Ratings
Price
$14.39
Total
25
Raised
0
Lowered
6
Avg PT
$13.75
H / L
$19 / $10
| Institution | Action | Rating | Date |
|---|---|---|---|
B of A Securities | Downgraded | Neutral → Underperform | 2026-06-29 |
HC Wainwright & Co. | Reiterated | Neutral | 2026-05-26 |
Morgan Stanley | Reiterated | Overweight | 2026-05-13 |
RBC Capital | Reiterated | Outperform | 2026-05-05 |
Citigroup | Reiterated | Buy | 2026-04-02 |
TD Cowen | Reiterated | Buy | 2026-03-11 |
UBS | Downgraded | Buy → Neutral | 2025-11-26 |
JP Morgan | Reiterated | Overweight | 2025-11-20 |
BTIG | Reiterated | Buy | 2025-11-18 |
Bernstein | Downgraded | Outperform → Market Perform | 2025-11-06 |
William Blair | Downgraded | Outperform → Market Perform | 2025-11-05 |
Baird | Reiterated | Outperform | 2025-08-12 |
Leerink Partners | Reiterated | Outperform | 2025-08-12 |
Cantor Fitzgerald | Reiterated | Overweight | 2024-12-17 |
Piper Sandler | Reiterated | Overweight | 2023-11-15 |
SVB Leerink | Reiterated | Outperform | 2023-01-24 |
Wedbush | Downgraded | Outperform → Neutral | 2022-08-08 |
Mizuho | Reiterated | Buy | 2022-03-03 |
Goldman Sachs | Reiterated | Buy | 2021-10-06 |
Canaccord Genuity | Reiterated | Buy | 2021-08-03 |
Cowen & Co. | Reiterated | Outperform | 2020-04-17 |
Oppenheimer | Reiterated | Perform | 2020-03-31 |
PiperJaffray | Reiterated | Overweight | 2019-05-08 |
Leerink Swann | Reiterated | Outperform | 2018-11-13 |
Barclays | Downgraded | Overweight → Equal Weight | 2018-04-05 |
One row per institution, most recent rating